Heron Therapeutics, Inc. earnings per share and revenue

HRTX earnings per share for the last quarter are -0.03 USD whereas the estimation was -0.04 USD which accounts for 20.79% surprise. Company revenue for the same period amounts to 32.81 M USD despite the estimated figure of 36.77 M USD. Estimated earnings per share for the next quarter are -0.02 USD, and revenue is expected to reach 39.73 M USD. Also watch annual changes over time to get a bigger picture of HRTX earnings per share and revenue dynamics.